Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSwitching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL.AuthorsCasado, JL; Domingo, P; Rubio, R; Antela, A; Lopez-Ruz, MA; Castro, A; Portilla, J; Ribera, E; Podzamczer, D; Oteo, JA; Galindo, J; Otero, S; Lozano, F; Estrada, V; Moltó, J; Moreno, SAbstract7-11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UKSubjectsTIPRANAVIR (Drug); RITONAVIR; HIV infections; THERAPEUTICSPublicationJournal of the International AIDS Society, 2010, Vol 13, pP49ISSN1758-2652Publication typeArticleDOI10.1186/1758-2652-13-S4-P49